NDC 51552-0456-07: Bupivacaine HCl 1 g/g Powder, 1000 g
This is a package of 1,000 g of Bupivacaine HCl 1 g/g Powder from Fagron Inc, first listed with the FDA Apr 1998 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 51552-0456-7 alone.
- Record
- FDA NDC Directory package listing · Bulk ingredient
- Code segments
- 51552 labeler · 0456 product · 7 package
- Package marketed since
- Apr 1, 1998
- Package marketing ended
- Jul 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 5155204567 5
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 023247
- GCN: 90059
- GPI-14 (Medi-Span): 69100010102900
- HICL (First Databank): 001470
- AHFS class code: 72:00.00.00
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It numbs an area or blocks pain during surgery, dental work, childbirth-related procedures, and diagnostic procedures. Exparel and Xaracoll are specifically used for pain relief af...
- A trained clinician injects it, so you don't take it at home. The injection type depends on your procedure, such as near a nerve, into tissue, or in the epidural or spinal area. Th...
- Nausea, vomiting, constipation, dizziness, headache, and low blood pressure have been reported. Fever and headache were seen with Exparel nerve blocks. Tell your team right away ab...
- It crosses the placenta and can affect the mother, baby, and newborn. It must not be used for paracervical block, and the 0.75% strength is not recommended for epidural anesthesia...
Patient education
Drug interactions
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 51552-0456-02 51552-0456-2 Main listing | 5 g in 1 CONTAINER | — | — | Active |
| 51552-0456-04 51552-0456-4 | 25 g in 1 CONTAINER | — | — | Active |
| 51552-0456-05 51552-0456-5 | 100 g in 1 CONTAINER | — | — | Active |
| 51552-0456-07 You're viewing this | 1000 g in 1 CONTAINER | — | — | Active |
You're viewing the largest of 4 pack sizes for this product.
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 51552-0456-02?
What NDC number is used to bill for this package of Bupivacaine HCl 1 g/g Powder?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Bupivacaine HCl 1 g/gthis 51552-0456-07 | Fagron | 1000 g | — | — | FDA listed | — |
| Bupivacaine HCl 1 g/g 73377-0239-01 | AX | 2500 g | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Bupivacaine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Fagron Inc labeler code 51552
- Hydroxypropylcell 1000-3000 CPS 1 g/g Powder NDC 51552-0299-5
- Ketoprofen 1 g/g Powder NDC 51552-0307-4
- Papaverine HCl 1 g/g Powder NDC 51552-0416-4
- Cromolyn Sodium 1 g/g Powder NDC 51552-0423-4
- Sodium Bisulfite 1 g/g Powder NDC 51552-0448-4
- Epinephrine Bitartrate 1 mg/mg Powder NDC 51552-0454-9
- Tetracycline Hydrochloride 1 g/g Powder NDC 51552-0463-5
- Amitriptyline HCl 1 g/g Powder NDC 51552-0464-4
- Diclofenac Sodium 1 g/g Powder NDC 51552-0482-6
- Cyclobenzaprine Hcl 1 g/g Powder NDC 51552-0483-2
- Hydroxyzine HCl 1 g/g Powder NDC 51552-0485-9
- Tranexamic Acid 1 g/g Powder NDC 51552-0513-5
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2026 (Q1)
About this NDC listing & data coverage
This is a bulk ingredient listing — not a retail prescription package
Bupivacaine HCl 1 g/g POWDER is listed with FDA as a bulk ingredient (a drug substance supplied for further manufacturing or licensed pharmacy compounding). It is not a finished product a patient would receive at a retail pharmacy, so consumer-style information — a patient label, retail pricing, package photos — generally does not exist for this NDC. The listing identifies the substance and package for supply-chain and regulatory purposes.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |